Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies

Overview of attention for article published in Drugs, July 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 3,046 followers.

Targeting #BCL2 in Chronic Lymphocytic #Leukemia and Other Hematologic Malignancies #CLL https://t.co/ewkUb0BzFZ https://t.co/C7BFTKn9Kb

Reply Repost Favourite

Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies. #lymphoma #lymsm https://t.co/B4z8MdmM0h

Reply Repost Favourite

Willima Wierda and colleagues from the @MDAndersonNews discuss targeting BCL2 in #CLL and other haematological malignancies #Venclexta included https://t.co/yFbJ2CdJ5U

Reply Repost Favourite

Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies. #lymphoma #lymsm https://t.co/B4z8MdmM0h

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.